Infectious diseases experts applaud bill against 'bad bugs'

October 31, 2007

Arlington, VA--With methicillin-resistant Staphylococcus aureus (MRSA) infections, extensively drug-resistant tuberculosis, and other "bad bugs" routinely making headlines, infectious diseases physicians are applauding Sens. Sherrod Brown (D-OH) and Orrin Hatch (R-UT) for introducing in the Senate the Strategies To Address Antimicrobial Resistance (STAAR) Act. The STAAR Act was introduced in the House of Representatives in September by Reps. Jim Matheson (D-UT) and Rep. Mike Ferguson (R-NJ).

"The STAAR Act has the potential to save thousands of lives," said Donald M. Poretz, MD, president of the Infectious Diseases Society of America (IDSA). "IDSA strongly supports the STAAR Act and the comprehensive approach that Sens. Brown and Hatch are taking to tackle the problem of antimicrobial resistance. Infectious diseases physicians have watched in dismay for years as the antibacterials and other antimicrobials we rely upon to treat our patients have lost their power."

To make matters worse, there are very few new drugs in the pipeline to replace the failing ones, because the pharmaceutical industry now finds developing new antibiotics less appealing than developing drugs for chronic conditions like heart disease. "We are in danger of slipping backward to the era before antibiotics," Dr. Blaser added. "The STAAR Act gets us back in the fight by enhancing federal leadership, encouraging expert input, and by improving our grasp on resistance and ways to control it."

"The issue goes beyond just the pharmaceutical industry," Dr. Blaser said. "We are all in this together--drug companies, physicians, public health experts, and patients. The STAAR Act makes everyone a partner in the solution."

The bill takes a holistic approach to address inappropriate use, a significant problem that diminishes the effectiveness of antibiotics once they are approved.

It vastly improves the nation's capacity to control resistance by establishing a network of experts across the country to conduct regional monitoring of resistant organisms as they occur--a kind of "snapshot" to pick up on problems early.

"It's a different world versus even five years ago," said Neil Fishman, MD, chair of IDSA's Antimicrobial Resistance Work Group. "In addition to MRSA, multi-drug resistant bugs like Klebsiella have cropped up and spread practically before anyone has had the chance to examine them under the microscope, much less do anything to stop their spread." The STAAR Act sets up a network to collaborate with the Centers for Disease Control and Prevention on disease surveillance. "The network will be CDC's extra eyes and ears looking out for resistant bugs around the nation and finding ways to prevent their spread," Dr. Fishman added.

In a second major activity of the network, researchers also would work with CDC and the National Institutes of Health to find ways to slow the development of resistance. "We need to determine the best ways to keep approved antibiotics working longer," said Louis Rice, MD, chair of IDSA's Research on Resistance Work Group. "Currently, very little research is focusing on this. The STAAR Act network provides the range of experts we need to study the complex field of drug resistance."

The STAAR Act also creates a board of infectious diseases, public health and veterinary experts to advise the federal government on reducing resistance, and an Office of Antimicrobial Resistance in the Department of Health and Human Services to coordinate, help plan, and guide the government's response to resistance.

IDSA thanks Sens. Brown and Hatch, as well as Reps. Matheson and Ferguson for their leadership in introducing this important patient safety and public health bill, and encourages Congress to pass it quickly.

"IDSA has been warning that the 'bad bugs' are getting ahead of us," Dr. Blaser said. "We are glad to see Congress is listening. But we need this legislation to pass soon. It takes years to develop a new drug, and to strengthen and implement new control strategies. These bad bugs are not waiting."
Find a summary of the STAAR Act and other related information at

IDSA is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, prevention, and patient care. The Society, which has more than 8,000 members, was founded in 1963 and is based in Arlington, VA. For more information, visit

Infectious Diseases Society of America

Related Antibiotics Articles from Brightsurf:

Insights in the search for new antibiotics
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that addresses the gap in the discovery of new antibiotics.

New tricks for old antibiotics
The study published in the journal Immunity reveals that tetracyclines (broad spectre antibiotics), by partially inhibiting cell mitochondria activity, induce a compensatory response on the organism that decreases tissue damage caused during infection.

Benefits, risks seen with antibiotics-first for appendicitis
Antibiotics are a good choice for some patients with appendicitis but not all, according to study results published today in the New England Journal of Medicine.

How antibiotics interact
Understanding bottleneck effects in the translation of bacterial proteins can lead to a more effective combination of antibiotics / study in 'Nature Communications'

Are antivitamins the new antibiotics?
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

Hygiene reduces the need for antibiotics by up to 30%
A new paper published in the American Journal of Infection Control (AJIC), finds improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections by up to 50%, reducing the need for antibiotics, by up to 30%.

Antibiotics: City dwellers and children take the most
City dwellers take more antibiotics than people in rural areas; children and the elderly use them more often than middle-aged people; the use of antibiotics decreases as education increases, but only in rich countries: These are three of the more striking trends identified by researchers of the NRW Forschungskolleg ''One Health and Urban Transformation'' at the University of Bonn.

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

Antibiotics from the sea
The team led by Prof. Christian Jogler of Friedrich Schiller University, Jena, has succeeded in cultivating several dozen marine bacteria in the laboratory -- bacteria that had previously been paid little attention.

Antibiotics not necessary for most toothaches, according to new ADA guideline
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches.

Read More: Antibiotics News and Antibiotics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to